Zynerba Pharmaceuticals Inc. (ZYNE) Is Losing Ground On Offering News

Zynerba Pharmaceuticals Inc. (ZYNE) announced after the bell Thursday that it intends to offer and sell shares of its common stock in an underwritten public offering. The stock is now down 1.67 on 21K shares.

Zynerba Pharmaceuticals traded in a range for the majority of Thursday’s session and closed up by 0.24 at $410.42.

by RTTNews Staff Writer

Source: Read Full Article